BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24928630)

  • 1. Tetrahydrocoptisine protects rats from LPS-induced acute lung injury.
    Li W; Huang H; Niu X; Fan T; Hu H; Li Y; Yao H; Li H; Mu Q
    Inflammation; 2014 Dec; 37(6):2106-15. PubMed ID: 24928630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
    Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
    Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effect of tetrahydrocoptisine from Corydalis impatiens is a function of possible inhibition of TNF-α, IL-6 and NO production in lipopolysaccharide-stimulated peritoneal macrophages through inhibiting NF-κB activation and MAPK pathway.
    Li W; Huang H; Zhang Y; Fan T; Liu X; Xing W; Niu X
    Eur J Pharmacol; 2013 Sep; 715(1-3):62-71. PubMed ID: 23810685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The total alkaloids of Aconitum tanguticum protect against lipopolysaccharide-induced acute lung injury in rats.
    Wu G; Du L; Zhao L; Shang R; Liu D; Jing Q; Liang J; Ren Y
    J Ethnopharmacol; 2014 Sep; 155(3):1483-91. PubMed ID: 25102245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
    Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
    J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and transforming growth factor -β/Smad signaling pathway].
    Mu E; Ding R; An X; Li X; Chen S; Ma X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):810-4. PubMed ID: 25399896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aloin suppresses lipopolysaccharide-induced acute lung injury by inhibiting NLRP3/NF-κB via activation of SIRT1 in mice.
    Lei J; Shen Y; Xv G; Di Z; Li Y; Li G
    Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):306-313. PubMed ID: 32419528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of lidocaine on lipopolysaccharide-induced acute lung injury in rats through NF-κB and p38 MAPK signaling pathway and excessive inflammatory responses.
    Chen LJ; Ding YB; Ma PL; Jiang SH; Li KZ; Li AZ; Li MC; Shi CX; Du J; Zhou HD
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2099-2108. PubMed ID: 29687869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
    Huang Y; Huang L; Zhu G; Pei Z; Zhang W
    J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolvin D1 protects mice from LPS-induced acute lung injury.
    Wang B; Gong X; Wan JY; Zhang L; Zhang Z; Li HZ; Min S
    Pulm Pharmacol Ther; 2011 Aug; 24(4):434-41. PubMed ID: 21501693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
    Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G
    Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
    Zhang T; Wang J; Wang S; Ma C
    Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
    Jing W; Chunhua M; Shumin W
    Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway.
    Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB
    Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
    Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
    Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats.
    Tsai CL; Lin YC; Wang HM; Chou TC
    J Ethnopharmacol; 2014 Apr; 153(1):197-206. PubMed ID: 24534526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
    Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
    Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.